Researchers from the Casey Eye Institute at the Oregon Health & Science University are reporting the successful use of CRISPR gene-editing to restore vision for patients with a rare eye disease. Leber congenital amaurosis, or LCA, is an uncommon genetic form of vision … [Read more...] about CRISPR gene-editing restores vision in patients with rare eye disease
CRISPR
CRISPR technology shows promise in treating rare genetic disease
CRISPR technology has been used to successfully treat sickle cell disease, and now, the CRISPR gene-editing tool has been shown to work safely and effectively when used inside the patient’s body, or 'in vivo,' for the first time. CRISPR conducts cut-and-paste edits to the … [Read more...] about CRISPR technology shows promise in treating rare genetic disease
Scientists successfully use CRISPR to lower cholesterol in monkeys
Did you know that as it stands, approximately one person every 36 seconds dies in the US from cardiovascular disease? Thanks to scientists from the University of Pennsylvania and private company Verve Therapeutics, this dismal statistic may soon change for the better. The … [Read more...] about Scientists successfully use CRISPR to lower cholesterol in monkeys
Could this be the solution to antibiotic-resistant bacteria?
We recently shared an article about a new technique to better treat infections and reduce the development of antibiotic-resistant bacteria, but as these superbugs become more common, we will need a multi-pronged public health response to the crisis. Another potential solution for … [Read more...] about Could this be the solution to antibiotic-resistant bacteria?
First CRISPR gene editing patients continue to show positive progress
Back in June, we shared the success story of Victoria Gray, the first person in the US with a genetic disorder to get treated with the revolutionary gene-editing technique called CRISPR. Now, a year and a half since her groundbreaking treatment, Gray continues to thrive and even … [Read more...] about First CRISPR gene editing patients continue to show positive progress